News

Filter

Current filters:

None

46 to 55 of 98147 results

Janssen acquires UK virtual biopharma firm XO1

24-03-2015

US health care giant Johnson & Johnson subsidiary Janssen Pharmaceuticals, has acquired XO1 Limited,…

BiotechnologyCardio-vascularichorcumabJanssenJohnson & JohnsonMergers & AcquisitionsUKXO1 Limited

ThromboGenics announces positive data from 24-month followup study of Jetrea

ThromboGenics announces positive data from 24-month followup study of Jetrea

24-03-2015

Ophthalmic medicine specialist ThromboGenics has announced positive top-line results from its study of…

JetreaOphthalmicsPharmaceuticalResearchThromboGenics

Cardio3 Biosciences opens US manufacturing facility

Cardio3 Biosciences opens US manufacturing facility

24-03-2015

European cell therapy specialist Cardio3 BioSciences is to open a new USA-based manufacturing facility…

BiotechnologyCardio3 BioSciencesCardio3 BioSciencesProductionUSA

Teva's anti-migraine drug TEV-48125 achieves primary and secondary endpoints at Phase IIb

Teva's anti-migraine drug TEV-48125 achieves primary and secondary endpoints at Phase IIb

24-03-2015

Israel-based Teva Pharmaceutical Industries says that its investigational drug TEV-48125 achieved the…

AnalgesiaIsraelNeurologicalPharmaceuticalResearchTEV-48125Teva

FDA safety review of Zyprexa Relprevv calls for no changes to current prescribing

24-03-2015

The US Food and Drug Administration has concluded a review of a study undertaken to determine the cause…

Eli LillyHealthcareNeurologicalPharmaceuticalRegulationUSAZyprexa Relprevv

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

Regenerative Medicine Expert Group publishes report with action plan for UK implementation

24-03-2015

The Regenerative Medicine Expert Group has published its report ‘Building on our own potential: a UK…

BiotechnologyPricingRegulationResearchUK

97% of Australians want new cancer medicines subsidized through PBS

24-03-2015

New findings released by Newspoll shows overwhelming support for access to new cancer medicines through…

AustraliaFinancialHealthcareOncologyPharmaceutical

Novo Nordisk’s Saxenda gains EU approval for obesity

24-03-2015

There was good news for Danish diabetes care giant Novo Nordisk yesterday, when, late in the day, the…

DiabetesEuropeMetabolicsNovo NordiskPharmaceuticalRegulationSaxendaVictoza

Takeda in-licenses ImmunoGen’s antibody-drug conjugate technology

Takeda in-licenses ImmunoGen’s antibody-drug conjugate technology

23-03-2015

US biotech firm ImmunoGen (Nasdaq: IMGN) saw its shares leap 17% to $8.74 in early morning trading on…

BiotechnologyImmunoGenLicensingOncologyTakeda Pharmaceutical

46 to 55 of 98147 results

Back to top